9 Even though the trial failed to reach significance in improving dystonia at 18 months for all patients, subgroup analysis on classic and atypical PKAN suggests that the stage of the disease is a determining factor in response to treatment.
1
—
—
9 Even though the trial failed to reach significance in improving dystonia at 18 months for all patients, subgroup analysis on classic and atypical PKAN suggests that the stage of the disease is a determining factor in response to treatment.